Search

everythinglearnresearchcommunity

for

Search:↓

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.